 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/17/2024 |
$0.20 |
$0.21 |
$0.19 |
$0.19 |
1.24M | | 04/18/2024 |
$0.19 |
$0.20 |
$0.18 |
$0.19 |
957.80K | | 04/19/2024 |
$0.20 |
$0.20 |
$0.18 |
$0.19 |
388.90K | | 04/22/2024 |
$0.20 |
$0.20 |
$0.18 |
$0.18 |
1.38M | | 04/23/2024 |
$0.18 |
$0.19 |
$0.18 |
$0.18 |
766.60K |
|
|
| Matinas Biopharma Holdings is a biopharmaceutical company focused on development of its product candidate: MAT9001, a purified, prescription-only omega-3 free fatty acid formulation designed for the treatment of cardiovascular and metabolic conditions; and the application of its lipid nano-crystal (LNC) platform delivery technology to solve challenges relating to the delivery of small molecules, vaccines, proteins and peptides. Co.'s lead drug candidate based on the LNC platform delivery technology is MAT2203, which is an antifungal drug. Co.'s second clinical stage LNC-based product candidate is MAT2501, an orally administered formulation of aminoglycoside antibiotic amikacin. | |
|
Matinas BioPharma Holdings (MTNB) has the following price history information. Looking back at MTNB historical stock prices for the last five trading days, on April 17, 2024, MTNB opened at $0.20, traded as high as $0.21 and as low as $0.19, and closed at $0.19. Trading volume was a total of 1.24M shares. On April 18, 2024, MTNB opened at $0.19, traded as high as $0.20 and as low as $0.18, and closed at $0.19. Trading volume was a total of 957.80K shares. On April 19, 2024, MTNB opened at $0.20, traded as high as $0.20 and as low as $0.18, and closed at $0.19. Trading volume was a total of 388.90K shares. On April 22, 2024, MTNB opened at $0.20, traded as high as $0.20 and as low as $0.18, and closed at $0.18. Trading volume was a total of 1.38M shares. On April 23, 2024, MTNB opened at $0.18, traded as high as $0.19 and as low as $0.18, and closed at $0.18. Trading volume was a total of 766.60K shares.
MTNB Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Matinas BioPharma Holdings shares, starting with a $10,000 purchase of MTNB, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
07/22/2014 |
|
| End date: |
04/23/2024 |
|
| Start price/share: |
$1.17 |
|
| End price/share: |
$0.18 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-84.44% |
|
| Average Annual Total Return: |
-17.36% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,554.68 |
|
| Years: |
9.76 |
|
|
|
| Date |
Close |
| 04/17/2024 | $0.19 | | 04/18/2024 | $0.19 | | 04/19/2024 | $0.19 | | 04/22/2024 | $0.18 | | 04/23/2024 | $0.18 |
|
|
Free MTNB Email Alerts:
